These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6839994)

  • 21. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo.
    Romi F; Kristoffersen EK; Aarli JA; Gilhus NE
    J Neuroimmunol; 2005 Jan; 158(1-2):191-4. PubMed ID: 15589053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.
    Kida K; Hayashi M; Yamada I; Matsuda H; Yoshinaga J; Takami S; Yashiki S; Sonoda S
    Ann Neurol; 1987 Mar; 21(3):274-8. PubMed ID: 3606034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
    Scherbaum WA; Schumm F
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group.
    Hartung K; Coldewey R; Röther E; Pirner K; Specker C; Schendel D; Stangel W; Stannat-Kiessling S; de Lange GG
    Rheumatol Int; 1991; 11(4-5):179-82. PubMed ID: 1784886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reactivity to hepatitis B vaccination (HBV) in patients with uremia: association with defined HLA antigen configuration and complement protein allotypes C4A, C4B and B factor (Bf)].
    Stachowski J; Runowski D; Kramer J; Madaliński K; Maciejewski J; Baldamus CA
    Przegl Lek; 1995; 52(9):445-54. PubMed ID: 8834646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gm allotypes in Finnish myasthenia gravis patients.
    Smith CI; Grubb R; Hammarström L; Pirskanen R
    Neurology; 1984 Dec; 34(12):1604-5. PubMed ID: 6504334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.
    Keesey J; Naiem F; Lindstrom J; Roe D; Herrmann C; Walford R
    Arch Neurol; 1982 Feb; 39(2):73-7. PubMed ID: 6977352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis and HLA antigens in American blacks and other races.
    Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
    J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DR2, [HLA-B7, SC31, DR2], and [HLA-B8, SC01, DR3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy.
    Blumenthal M; Marcus-Bagley D; Awdeh Z; Johnson B; Yunis EJ; Alper CA
    J Immunol; 1992 Jan; 148(2):411-6. PubMed ID: 1729361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
    Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
    Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma.
    Gilhus NE; Pandey JP; Gaarder PI; Aarli JA
    J Autoimmun; 1990 Jun; 3(3):299-305. PubMed ID: 2397020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.
    Rødgaard A; Nielsen FC; Djurup R; Somnier F; Gammeltoft S
    Clin Exp Immunol; 1987 Jan; 67(1):82-8. PubMed ID: 3621677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis.
    Donaldson PT; Farrant JM; Wilkinson ML; Hayllar K; Portmann BC; Williams R
    Hepatology; 1991 Jan; 13(1):129-33. PubMed ID: 1988334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No significant correlation of HLA-B8 and amount of antibodies directed to acetylcholine receptor protein in patients with myasthenia gravis.
    Smith CI; Hammarström L; Möller E; Lefvert AK; Matell G
    Tissue Antigens; 1978 Nov; 12(5):387-95. PubMed ID: 85354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients.
    Tüzün E; Yılmaz V; Parman Y; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Med Princ Pract; 2011; 20(6):581-3. PubMed ID: 21986021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis.
    Naeim F; Keesey JC; Herrmann C; Lindstrom J; Zeller E; Walford RL
    Tissue Antigens; 1978 Nov; 12(5):381-6. PubMed ID: 85353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiacetylcholine receptor antibody and its relationship to HLA type in asymptomatic siblings of a patient with myasthenia gravis.
    Seybold ME; Lindstrom JM
    Neurology; 1981 Jun; 31(6):778-80. PubMed ID: 7195498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.